Global Health Limited (ASX:GLH) Advances Digital Health Platform Transition

Aditi Sarkar

23 September 2026 04:38 PM AEST

Global Health Limited (ASX:GLH) Advances Digital Health Platform Transition

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights:

Global Health completed the upgrade of its provider applications to a multi-tenanted SaaS architecture during FY26.
ARR subscription and expansion Revenue increased 5.5% to $6.674 million, representing 93% of customer revenue.
EBITDA loss improved by 28% to $545,000 after fully expensed R&D.
The company expanded AI initiatives across its healthcare technology platforms, including MasterCare solutions.

Global Health Limited (ASX:GLH) reported FY2026 results reflecting progress in its technology transition, revenue mix improvement and cost management initiatives. During the year, the company completed a major Investment program upgrading its three on-premises provider applications to MasterCare Plus, a configurable multi-tenanted SaaS Business model. The company stated that the transition has positioned its provider, consumer and digital front-door platforms for further development.

ARR Growth and SaaS Platform Expansion

Global Health’s FY26 performance reflected a shift towards recurring subscription-based revenue streams. Core ARR subscription and expansion revenue increased 5.5% to $6.674 million, with ARR subscription revenue accounting for 93% of total customer revenue.

Subscription revenue across the company’s SaaS platforms increased by $255,000, or 14.2%, to $2.051 million. This represented 31% of total ARR subscriptions. During FY26, more than 30 new-logo and existing on-premises clients adopted one or more SaaS platforms, including MasterCare Plus, HotHealth Digital Front Door and ReferralNet Secure Messaging.

Total customer revenue was $7.184 million, down $134,000 compared with the previous corresponding period. The decline was mainly associated with a $530,000 reduction in professional services revenue, which decreased following greater use of automated onboarding processes and Training resources.

Cost Reduction and Improved Financial Metrics

Global Health recorded improvements across key financial measures during FY26. Total operating expenses, including Research and Development costs, reduced by $880,000 to $8.577 million, representing a 9% reduction.

The company reported EBITDA after fully expensed R&D improved by 28%, moving from a loss of $760,000 in FY25 to a loss of $545,000 in FY26. Profit before tax also improved by 13%, from a loss of $866,000 to a loss of $758,000.

The company attributed part of the cost improvement to operational changes and the adoption of artificial intelligence initiatives. Employee and operational contractor costs declined by $1.353 million compared with the previous corresponding period, while the company continued integrating AI features across its platforms.

AI Integration and Future Technology Focus

During FY26, Global Health expanded its use of AI across its healthcare software ecosystem. The company released AI Assistants within its MasterCare EMR and MasterCare Plus platforms to support users with application guidance and training.

The company also entered into a partner agreement with Heidi Health, integrating clinical scribe and decision-support capabilities into MasterCare EMR and MasterCare Plus platforms. Additional AI initiatives include an AI receptionist and an AI-powered avatar within the Lifecard Personal Health Record platform.

Looking ahead, Global Health plans to focus on increasing ARR and improving margins following completion of the major SaaS technology upgrade. The company expects to allocate part of the R&D savings towards business development, with additional sales resources planned from the first quarter of FY2027.

The company also completed integration of its HotHealth digital front door and ReferralNet Secure Messaging platforms with Best Practice systems and plans to continue developing digital healthcare solutions.

Key Insights

Global Health’s FY26 results highlight the company’s transition towards SaaS-based healthcare technology solutions, with higher Recurring Revenue contribution and reduced operating costs. The completion of its platform upgrade, continued AI integration and focus on expanding digital healthcare solutions remain central elements of its ongoing strategy.

FAQs

Q: What were Global Health’s key FY26 financial results?

A:Global Health reported ARR subscription and expansion revenue of $6.674 million, reduced operating expenses to $8.577 million and improved EBITDA loss to $545,000 in FY26.

Q: What technology upgrade did Global Health complete in FY26?

A:The company upgraded its three on-premises provider applications to MasterCare Plus, a multi-tenanted configurable SaaS platform.

Q: How did subscription revenue perform during FY26?

A:SaaS platform subscription revenue increased by $255,000, or 14.2%, to $2.051 million during FY26.

Q: How is Global Health incorporating AI into its platforms?

A:The company introduced AI Assistants in MasterCare EMR and MasterCare Plus and continued development of AI-enabled healthcare tools.

Q: What are Global Health’s FY27 focus areas?

A:The company plans to focus on ARR growth, margin improvement, business development expansion and continued digital healthcare platform development.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.